Cargando…
Essential thrombocytemia following immune thrombocytopenia with JAK2V617F mutation
JAK2(V617F) mutation is found in about 60% of cases of essential thrombocytemia (ET) and represents a driving mutation. Immune thrombocytopenia (ITP) is an autoimmune disease characterized by a low platelet (PLT) count. So far, only 2 reports described ET following ITP. For the first time we analyze...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758937/ https://www.ncbi.nlm.nih.gov/pubmed/29326868 http://dx.doi.org/10.1016/j.lrr.2017.12.002 |
_version_ | 1783291096340627456 |
---|---|
author | Caocci, Giovanni Atzeni, Sandra Usai, Monica La Nasa, Giorgio |
author_facet | Caocci, Giovanni Atzeni, Sandra Usai, Monica La Nasa, Giorgio |
author_sort | Caocci, Giovanni |
collection | PubMed |
description | JAK2(V617F) mutation is found in about 60% of cases of essential thrombocytemia (ET) and represents a driving mutation. Immune thrombocytopenia (ITP) is an autoimmune disease characterized by a low platelet (PLT) count. So far, only 2 reports described ET following ITP. For the first time we analyzed in a patient the JAK2(V617F) allele burden at ITP onset occurred 13 years before the ET diagnosis and found the presence of a small clone JAK2(V617F) positive clone (3%) raised to 27% in the following years. The association of ET and ITP could suggest similar pathogenetic mechanisms that should be further investigated. |
format | Online Article Text |
id | pubmed-5758937 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-57589372018-01-11 Essential thrombocytemia following immune thrombocytopenia with JAK2V617F mutation Caocci, Giovanni Atzeni, Sandra Usai, Monica La Nasa, Giorgio Leuk Res Rep Article JAK2(V617F) mutation is found in about 60% of cases of essential thrombocytemia (ET) and represents a driving mutation. Immune thrombocytopenia (ITP) is an autoimmune disease characterized by a low platelet (PLT) count. So far, only 2 reports described ET following ITP. For the first time we analyzed in a patient the JAK2(V617F) allele burden at ITP onset occurred 13 years before the ET diagnosis and found the presence of a small clone JAK2(V617F) positive clone (3%) raised to 27% in the following years. The association of ET and ITP could suggest similar pathogenetic mechanisms that should be further investigated. Elsevier 2017-12-27 /pmc/articles/PMC5758937/ /pubmed/29326868 http://dx.doi.org/10.1016/j.lrr.2017.12.002 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Caocci, Giovanni Atzeni, Sandra Usai, Monica La Nasa, Giorgio Essential thrombocytemia following immune thrombocytopenia with JAK2V617F mutation |
title | Essential thrombocytemia following immune thrombocytopenia with JAK2V617F mutation |
title_full | Essential thrombocytemia following immune thrombocytopenia with JAK2V617F mutation |
title_fullStr | Essential thrombocytemia following immune thrombocytopenia with JAK2V617F mutation |
title_full_unstemmed | Essential thrombocytemia following immune thrombocytopenia with JAK2V617F mutation |
title_short | Essential thrombocytemia following immune thrombocytopenia with JAK2V617F mutation |
title_sort | essential thrombocytemia following immune thrombocytopenia with jak2v617f mutation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758937/ https://www.ncbi.nlm.nih.gov/pubmed/29326868 http://dx.doi.org/10.1016/j.lrr.2017.12.002 |
work_keys_str_mv | AT caoccigiovanni essentialthrombocytemiafollowingimmunethrombocytopeniawithjak2v617fmutation AT atzenisandra essentialthrombocytemiafollowingimmunethrombocytopeniawithjak2v617fmutation AT usaimonica essentialthrombocytemiafollowingimmunethrombocytopeniawithjak2v617fmutation AT lanasagiorgio essentialthrombocytemiafollowingimmunethrombocytopeniawithjak2v617fmutation |